ZA9811348B - Statin-carboxyalkylether combinations - Google Patents

Statin-carboxyalkylether combinations

Info

Publication number
ZA9811348B
ZA9811348B ZA9811348A ZA9811348A ZA9811348B ZA 9811348 B ZA9811348 B ZA 9811348B ZA 9811348 A ZA9811348 A ZA 9811348A ZA 9811348 A ZA9811348 A ZA 9811348A ZA 9811348 B ZA9811348 B ZA 9811348B
Authority
ZA
South Africa
Prior art keywords
carboxyalkylether
statin
combinations
carboxyalkylether combinations
Prior art date
Application number
ZA9811348A
Other languages
English (en)
Inventor
Charles Larry Bisgaier
Roger Schofield Newton
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA9811348B publication Critical patent/ZA9811348B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
ZA9811348A 1997-12-12 1998-12-10 Statin-carboxyalkylether combinations ZA9811348B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6937597P 1997-12-12 1997-12-12

Publications (1)

Publication Number Publication Date
ZA9811348B true ZA9811348B (en) 1999-06-14

Family

ID=22088573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811348A ZA9811348B (en) 1997-12-12 1998-12-10 Statin-carboxyalkylether combinations

Country Status (30)

Country Link
EP (1) EP1045691B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002508320A (cg-RX-API-DMAC7.html)
KR (1) KR20010033003A (cg-RX-API-DMAC7.html)
AR (1) AR017851A1 (cg-RX-API-DMAC7.html)
AT (1) ATE285762T1 (cg-RX-API-DMAC7.html)
AU (1) AU754089B2 (cg-RX-API-DMAC7.html)
BR (1) BR9813542A (cg-RX-API-DMAC7.html)
CA (1) CA2304612A1 (cg-RX-API-DMAC7.html)
CO (1) CO4970816A1 (cg-RX-API-DMAC7.html)
CR (1) CR5926A (cg-RX-API-DMAC7.html)
CU (1) CU20000140A7 (cg-RX-API-DMAC7.html)
DE (1) DE69828442T2 (cg-RX-API-DMAC7.html)
DK (1) DK1045691T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230733T3 (cg-RX-API-DMAC7.html)
GT (1) GT199800196A (cg-RX-API-DMAC7.html)
HN (1) HN1998000185A (cg-RX-API-DMAC7.html)
HU (1) HUP0004547A3 (cg-RX-API-DMAC7.html)
IL (1) IL135349A0 (cg-RX-API-DMAC7.html)
IS (1) IS2150B (cg-RX-API-DMAC7.html)
MY (1) MY118381A (cg-RX-API-DMAC7.html)
NO (1) NO20002966L (cg-RX-API-DMAC7.html)
NZ (1) NZ503982A (cg-RX-API-DMAC7.html)
PA (1) PA8464601A1 (cg-RX-API-DMAC7.html)
PE (1) PE20000017A1 (cg-RX-API-DMAC7.html)
PL (1) PL341066A1 (cg-RX-API-DMAC7.html)
PT (1) PT1045691E (cg-RX-API-DMAC7.html)
SV (1) SV1998000146A (cg-RX-API-DMAC7.html)
UY (1) UY25299A1 (cg-RX-API-DMAC7.html)
WO (1) WO1999030704A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA9811348B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
CA2299397A1 (en) * 1997-12-12 1999-06-24 Warner-Lambert Company Antihyperlipidemic statin-lp(a) inhibitor combinations
US20030105154A1 (en) 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
CZ20011035A3 (cs) * 1998-09-30 2001-10-17 Warner-Lambert Company Léčivo pro prevenci nebo oddálení revaskularizace pomocí katetru u pacientů postiľených chorobou koronární artérie
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
IN191580B (cg-RX-API-DMAC7.html) * 1999-12-17 2003-12-06 Ranbaxy Lab Ltd
NZ519550A (en) 2000-01-25 2003-11-28 Warner Lambert Co Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
AU2001256278A1 (en) * 2000-04-18 2001-10-30 Bayer Aktiengesellschaft Use of cse inhibitors for treating heart failure
CZ20023459A3 (cs) * 2000-04-26 2003-05-14 Warner-Lambert Company Antihypertensní činidla a jejich použití
US6689807B1 (en) * 2000-06-08 2004-02-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. HMG CoA reductase inhibitors for promoting angiogenesis
CA2450820C (en) * 2001-08-16 2011-03-15 Teva Pharmaceutical Industries Ltd. Processes for preparing calcium salt forms of statins
KR20040026705A (ko) 2001-08-16 2004-03-31 테바 파마슈티컬 인더스트리즈 리미티드 스타틴의 칼슘 염 형태의 제조 방법
US20050026979A1 (en) * 2003-07-31 2005-02-03 Maha Ghazzi Methods for treating inflammation and inflammation-associated diseases with a statin and ether
JP6295205B2 (ja) * 2012-01-06 2018-03-14 ジェムファイア セラピューティクス インクGemphire Therapeutics Inc. 心血管疾患のリスクを低減する方法
MX2018005096A (es) * 2015-11-06 2018-08-15 Gemphire Therapeutics Inc Combinaciones de gemcabeno para el tratamiento de enfermedad cardiovascular.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases

Also Published As

Publication number Publication date
NO20002966D0 (no) 2000-06-09
IL135349A0 (en) 2001-05-20
JP2002508320A (ja) 2002-03-19
EP1045691B1 (en) 2004-12-29
IS5445A (is) 2000-04-14
ES2230733T3 (es) 2005-05-01
GT199800196A (es) 2000-06-03
SV1998000146A (es) 1999-09-30
WO1999030704A1 (en) 1999-06-24
EP1045691A1 (en) 2000-10-25
HN1998000185A (es) 1999-06-02
CR5926A (es) 2000-03-06
DE69828442D1 (de) 2005-02-03
CA2304612A1 (en) 1999-06-24
KR20010033003A (ko) 2001-04-25
NO20002966L (no) 2000-06-09
BR9813542A (pt) 2000-10-10
AU1591599A (en) 1999-07-05
HUP0004547A3 (en) 2001-12-28
IS2150B (is) 2006-10-13
PA8464601A1 (es) 2001-12-14
MY118381A (en) 2004-10-30
CO4970816A1 (es) 2000-11-07
NZ503982A (en) 2002-03-28
PL341066A1 (en) 2001-03-26
AR017851A1 (es) 2001-10-24
ATE285762T1 (de) 2005-01-15
DK1045691T3 (da) 2005-03-14
PT1045691E (pt) 2005-03-31
CU20000140A7 (es) 2005-10-19
HUP0004547A2 (hu) 2001-05-28
AU754089B2 (en) 2002-11-07
PE20000017A1 (es) 2000-01-20
DE69828442T2 (de) 2005-06-02
UY25299A1 (es) 2001-08-27

Similar Documents

Publication Publication Date Title
DE69817801D1 (en) Arylsulfonylhydroxamsäurederivate
DE69830051D1 (en) Endotrachealtubus
DE69840493D1 (en) Tionseinlage
GB9702473D0 (en) Spraybooth
DE69810944D1 (en) Hydroperoxidzersetzungsverfahren
GB9705239D0 (en) Mopheads
DE59805100D1 (en) Containerbrücke
IL135349A0 (en) Statin-carboxyalkylether combinations
GB9709832D0 (en) Divineh
DE59803148D1 (en) Dimensionsstabile thermoplastische formmassen
DE69814118D1 (en) Anti-first-pass-effect-substanzen
GB9711918D0 (en) Penstation
GB2330366B (en) Catch-pits
DE59806884D1 (en) Dexamethason-gel
GB9708522D0 (en) Wordgame
GB9710855D0 (en) Quillow
GB2325848B (en) Cafetiere
GB2328633B (en) Wheelbrace
GB9713339D0 (en) G-seat
GB9704661D0 (en) Renovative pipeliner
CA82748S (en) Handleset
CA82218S (en) Sports-glasses
SI1045691T1 (en) Statin-carboxyalkylether combinations
GB9720281D0 (en) Digireader
GB9710534D0 (en) Textilsort